4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-21-017677
EVP, Chief Financial Officer sold 238 shares at $55.19 ($13,135)
- EVP, Chief Financial Officer acquired 24,305 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Burke William P. Mr. · EVP, Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-18 | Grant or award : show line 1 in the form | +6,628 | 17,746 | D | ||
| 2021-05-18 | Grant or award : show line 2 in the form | +17,677 | 35,423 | D | ||
| 2021-05-19 | Sale : show line 3 in the form | −238 | $55.19 | $13,135 | 35,185 | D |
| Open-market sales · 238 sh · avg $55.19 · $13,135 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-18 | Grant or award : show line 4 in the form Non-qualified Stock Option (Right to Buy) | +17,933 | 17,933 | D |
Loading xslF345X03/form4.xml…